149 related articles for article (PubMed ID: 21209173)
41. Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran.
Hasani A; Sheikhalizadeh V; Ahangarzadeh Rezaee M; Rahmati-Yamchi M; Hasani A; Ghotaslou R; Goli HR
Microb Drug Resist; 2016 Jul; 22(5):347-53. PubMed ID: 26779992
[TBL] [Abstract][Full Text] [Related]
42. Recent advances in antibiotics.
McAllister TA
Scott Med J; 1976 Oct; 21(4):210-7. PubMed ID: 793006
[No Abstract] [Full Text] [Related]
43. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
[TBL] [Abstract][Full Text] [Related]
44. [Soft-tissue infection caused by Aeromonas hydrophila].
Ramos JM; Cuenca-Estrella M; Esteban J; Soriano F
Enferm Infecc Microbiol Clin; 1995 Oct; 13(8):469-72. PubMed ID: 8555306
[TBL] [Abstract][Full Text] [Related]
45. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
46. The activity of ceftiofur sodium for Aeromonas spp. isolated from ornamental fish.
Dixon BA; Issvoran GS
J Wildl Dis; 1992 Jul; 28(3):453-6. PubMed ID: 1512880
[TBL] [Abstract][Full Text] [Related]
47. [Tetracyclines-induced phenotype and resistance mechanism in Aeromonas hydrophila].
Cui J; Wang D; Lu T; Li S
Wei Sheng Wu Xue Bao; 2016 Jul; 56(7):1149-58. PubMed ID: 29733176
[TBL] [Abstract][Full Text] [Related]
48. Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy.
Giltner CL; Bobenchik AM; Uslan DZ; Deville JG; Humphries RM
J Clin Microbiol; 2013 Apr; 51(4):1324-6. PubMed ID: 23363826
[TBL] [Abstract][Full Text] [Related]
49. Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
Ghotaslou R; Yeganeh Sefidan F; Akhi MT; Asgharzadeh M; Mohammadzadeh Asl Y
Microb Drug Resist; 2017 Oct; 23(7):826-832. PubMed ID: 28151044
[TBL] [Abstract][Full Text] [Related]
50. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
Reyonolds AV; Hamilton-Miller JM; Brumfitt W
J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
[TBL] [Abstract][Full Text] [Related]
51. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
52. Correlations between aminoglycoside consumption and aminoglycoside resistance in Gram-negative bacteria at a tertiary-care hospital in South Korea from 2001 to 2011.
Ku NS; Choi JY; Yong D; Kim JM; Lee K
Int J Antimicrob Agents; 2013 Apr; 41(4):394-5. PubMed ID: 23305659
[No Abstract] [Full Text] [Related]
53. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
[No Abstract] [Full Text] [Related]
54. In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
Ko WC; Lee HC; Chuang YC; Ten SH; Su CY; Wu JJ
Antimicrob Agents Chemother; 2001 Apr; 45(4):1281-3. PubMed ID: 11257047
[TBL] [Abstract][Full Text] [Related]
55. [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
Fosse T; Soussy CJ; Duval J
Pathol Biol (Paris); 1983 Jun; 31(6):483-7. PubMed ID: 6348654
[TBL] [Abstract][Full Text] [Related]
56. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Stratton CW; Weeks LS; Tausk F
J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
[TBL] [Abstract][Full Text] [Related]
57. Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
Habwe V; Shadomy S
J Antimicrob Chemother; 1979 Jan; 5(1):73-9. PubMed ID: 762007
[No Abstract] [Full Text] [Related]
58. [In-vitro activity of azithromycin in faecal isolates of Aeromonas hydrophila].
Jover-García J; Pérez-Doñate V; Colomina-Rodríguez J
An Pediatr (Barc); 2017 Apr; 86(4):226-227. PubMed ID: 27686393
[No Abstract] [Full Text] [Related]
59. Determinants of resistance to various aminoglycoside antibiotics.
Pisano A; Mattina R; Nicoletti G
Antibiotica; 1977 Mar; 14(1):58-72. PubMed ID: 879719
[No Abstract] [Full Text] [Related]
60. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
